Premium
Immune disorders in agnogenic myeloid metaplasia: relations to myelofibrosis
Author(s) -
Rondeau E.,
SolalCeligny P.,
Dhermy D.,
Vroclans M.,
Brousse N.,
Bernard J. F.,
Boivin P.
Publication year - 1983
Publication title -
british journal of haematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.907
H-Index - 186
eISSN - 1365-2141
pISSN - 0007-1048
DOI - 10.1111/j.1365-2141.1983.00459.x-i1
Subject(s) - myelofibrosis , medicine , autoantibody , myeloid , gastroenterology , immunology , pathology , antibody , bone marrow
S ummary . Tests for a dysimmune state were done in an unselected group of 67 patients with agnogenic myeloid metaplasia (AMM). The results were compared to those of 56 patients with polycythaemia vera (PV). 75% of AMM patients versus 32% of PV patients had various abnormalities. The most frequent disorders among AMM patients were serum antinuclear and anti smooth muscle autoantibodies (10 3% each), a positive test for rheumatoid factor (21 7%), a polyclonal increase in serum immunoglobulin levels (46 8%) or a serum monoclonal component (9 7%), a positive direct Coombs’test (19%), an anti I autoantibody (30%). In AMM patients there was no relationship between age, sex, importance of splenic enlargement, time from diagnosis or treatment and the present of a dysimmunity. Furthermore, in AMM patients, but also in PV patients, it seems that the more frequent and numerous these abnormalities the more severe is the myelofibrosis. Like other previous studies, these results suggest a lymphoid cell involvement in AMM and a role for these immune disorders in the pathogenesis of myelofibrosis.